摘要
目的分析瑞舒伐他汀与阿托伐他汀治疗早发冠心病急性心肌梗死的临床效果。方法选取冠心病急性心肌梗死患者94例,将其随机分为A组(瑞舒伐他汀治疗)与B组(阿托伐他汀治疗)。结果治疗后,两组患者TC、LDL-C、LVEE、Hs-CRP、FMD等与治疗前比较,明显改善,且A组TC、Hs-CRP优于B组。结论瑞舒伐他汀与阿托伐他汀治疗早发冠心病急性心肌梗死价值显著。
Objective To analyze the clinical effect of the treatment of acute myocardial infarction with the treatment of premature coronary heart disease with atorvastatin and atorvastatin. Methods 94 patients with acute myocardial infarction were randomly divided into A group （atorvastatin treatment） and B group （atorvastatin treatment）. Results After treatment, two groups of patients with TC LDL-C, LVEE, Hs-CRP, FMD and other compared with the treatment, significantly improved. TC, Hs-CRP, A is better than B group. Conclusions The value of atorvastatin and atorvastatin in the treatment of acute myocardial infarction with acute coronary heart disease is significant.
出处
《中国继续医学教育》
2015年第20期153-154,共2页
China Continuing Medical Education
